On-line Treatment for Conduct Problems
2015年2月4日 更新者:Alan E. Kazdin、Yale University
The research evaluates the use of online versions of delivering an effective psychological treatment for children clinically referred for serious oppositional, aggressive, and antisocial behavior.
The goal is to develop models of delivery that reach families in need that are not being served by in-person treatment.
The project has immediate implications for the treatment of children but more generally addresses several issues critical to treatments that are based on Internet, telepsychiatry, and related technologies.
研究概览
地位
完全的
研究类型
介入性
注册 (实际的)
86
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Connecticut
-
New Haven、Connecticut、美国、06511
- Yale Parenting Center
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
6年 至 12年 (孩子)
接受健康志愿者
不
有资格学习的性别
全部
描述
Inclusion Criteria:
- Diagnosis of Conduct Disorder of Oppositional Defiant Disorder (for the child)
- Residence in the state of CT
- Access to a computer and high-speed Internet access
- English fluency (at least one parent)
- No history of significant developmental delay (for the child)
- Parental consent
Exclusion Criteria:
- Participation in another form of psychotherapy or counseling that is directed toward the reduction of social, emotional, or behavioral problems
- Evidence of recent suicidality (for the child)
- Current or lifetime diagnosis of a Pervasive Developmental Disorder
- Primary diagnoses of a mood or anxiety disorder
- Acute family crisis
- Parent or guardian who can participate in treatment shows current psychosis or an uncontrolled medical condition
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
有源比较器:Online treatment, High therapist contact
Participants receive online Parent Management Training (interactive).
|
|
实验性的:Online treatment, Low therapist contact
Participants receive online Parent Management Training (recorded).
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Child Behavior Checklist
大体时间:Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
|
Internalizing and externalizing behavior problems in children
|
Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
|
Child Global Assessment Scale
大体时间:Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
|
Therapist-rated measure of overall child impairment and functioning
|
Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
|
Interview for Antisocial Behavior
大体时间:Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
|
Presence of a broad range of overt and covert antisocial behaviors in children
|
Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
|
Research Diagnostic Interview
大体时间:Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
|
Clinical symptoms and diagnoses based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) criteria
|
Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Parenting Stress Index
大体时间:Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
|
Sources of stress for the parent
|
Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
|
Beck Depression Inventory
大体时间:Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
|
Parental symptoms of depression
|
Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
|
Management of Child Behavior Scale
大体时间:Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
|
Parenting practices
|
Change from pretreatment (Week 0; immediately before the start of treatment) to posttreatment (immediately after treatment is completed; Week 8)
|
Parent-Therapist Relationship Scale (Therapist version)
大体时间:Midtreatment (Week 4 of treatment)
|
Characteristics of the therapeutic relationship according to therapist report
|
Midtreatment (Week 4 of treatment)
|
Parent-Therapist Relationship Scale (Therapist version)
大体时间:Posttreatment (immediately after treatment is completed; Week 8)
|
Characteristics of the therapeutic relationship according to therapist report
|
Posttreatment (immediately after treatment is completed; Week 8)
|
Parent-Therapist Relationship Scale (Parent version)
大体时间:Midtreatment (Week 4 of treatment)
|
Characteristics of the therapeutic relationship according to parent report
|
Midtreatment (Week 4 of treatment)
|
Parent-Therapist Relationship Scale (Parent version)
大体时间:Posttreatment (immediately after treatment is completed; Week 8)
|
Characteristics of the therapeutic relationship according to parent report
|
Posttreatment (immediately after treatment is completed; Week 8)
|
Barriers to Participation in Treatment (Therapist version)
大体时间:Midtreatment (Week 4 of treatment)
|
Stressors and obstacles that interfere with treatment
|
Midtreatment (Week 4 of treatment)
|
Barriers to Participation in Treatment (Therapist version)
大体时间:Posttreatment (immediately after treatment is completed; Week 8)
|
Stressors and obstacles that interfere with treatment
|
Posttreatment (immediately after treatment is completed; Week 8)
|
Barriers to Participation in Treatment (Parent version)
大体时间:Midtreatment (Week 4 of treatment)
|
Stressors and obstacles that interfere with treatment
|
Midtreatment (Week 4 of treatment)
|
Barriers to Participation in Treatment (Parent version)
大体时间:Posttreatment (immediately after treatment is completed; Week 8)
|
Stressors and obstacles that interfere with treatment
|
Posttreatment (immediately after treatment is completed; Week 8)
|
Weekly Participation in Treatment
大体时间:Weekly (during treatment)
|
Attendance and participation in treatment sessions
|
Weekly (during treatment)
|
Treatment Adherence Inventory (Therapist version)
大体时间:Midtreatment (Week 4 of treatment)
|
Parental compliance with specific treatment techniques
|
Midtreatment (Week 4 of treatment)
|
Treatment Adherence Inventory (Therapist version)
大体时间:Posttreatment (immediately after treatment is completed; Week 8)
|
Parental compliance with specific treatment techniques
|
Posttreatment (immediately after treatment is completed; Week 8)
|
Treatment Adherence Inventory (Parent version)
大体时间:Midtreatment (Week 4 of treatment)
|
Parental compliance with specific treatment techniques
|
Midtreatment (Week 4 of treatment)
|
Treatment Adherence Inventory (Parent version)
大体时间:Posttreatment (immediately after treatment is completed; Week 8)
|
Parental compliance with specific treatment techniques
|
Posttreatment (immediately after treatment is completed; Week 8)
|
Therapist Evaluation Inventory
大体时间:Midtreatment (Week 4 of treatment)
|
Acceptability of treatment based on therapist report
|
Midtreatment (Week 4 of treatment)
|
Therapist Evaluation Inventory
大体时间:Posttreatment (immediately after treatment is completed; Week 8)
|
Acceptability of treatment based on therapist report
|
Posttreatment (immediately after treatment is completed; Week 8)
|
Parent Evaluation Inventory
大体时间:Midtreatment (Week 4 of treatment)
|
Acceptability of treatment based on parent report
|
Midtreatment (Week 4 of treatment)
|
Parent Evaluation Inventory
大体时间:Posttreatment (immediately after treatment is completed; Week 8)
|
Acceptability of treatment based on parent report
|
Posttreatment (immediately after treatment is completed; Week 8)
|
Acceptability of Treatment Modality
大体时间:Midtreatment (Week 4 of treatment)
|
Parent-report measure rating the acceptability of online treatment and barriers that may affect participants receiving online treatment specifically
|
Midtreatment (Week 4 of treatment)
|
Acceptability of Treatment Modality
大体时间:Posttreatment (immediately after treatment is completed; Week 8)
|
Parent-report measure rating the acceptability of online treatment and barriers that may affect participants receiving online treatment specifically
|
Posttreatment (immediately after treatment is completed; Week 8)
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Perspectives on Treatment Interview
大体时间:Posttreatment (immediately after treatment is completed; Week 8)
|
Open-ended interview questions about parents' experiences in treatment and their impressions of different aspects of online treatment delivery
|
Posttreatment (immediately after treatment is completed; Week 8)
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Alan E. Kazdin, Ph.D.、Yale University
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2012年11月1日
初级完成 (实际的)
2014年12月1日
研究完成 (实际的)
2014年12月1日
研究注册日期
首次提交
2013年3月22日
首先提交符合 QC 标准的
2013年3月27日
首次发布 (估计)
2013年4月2日
研究记录更新
最后更新发布 (估计)
2015年2月6日
上次提交的符合 QC 标准的更新
2015年2月4日
最后验证
2015年2月1日
更多信息
与本研究相关的术语
其他研究编号
- 1108008914
- 1R34MH093326-01A1 (美国 NIH 拨款/合同)
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
品行障碍的临床试验
-
Hospital Universitari Vall d'Hebron Research InstituteInstituto de Salud Carlos III完全的
-
Dren BioNovotech招聘中侵袭性 NK 细胞白血病 | 肝脾T细胞淋巴瘤 | 肠病相关的T细胞淋巴瘤 | 皮下脂膜炎样 T 细胞淋巴瘤 | 单形性趋上皮性肠 T 细胞淋巴瘤 | LGLL - 大颗粒淋巴细胞白血病 | 原发性皮肤 T 细胞淋巴瘤 - 类别 | 原发性皮肤 CD8 阳性侵袭性嗜表皮 T 细胞淋巴瘤 | 系统性 EBV1 T 细胞淋巴瘤,如果 CD8 阳性 | Hydroa Vacciniforme-Like Lymphoproliferative Disorder | 结外 NK/T 细胞淋巴瘤,鼻型 | 胃肠道惰性慢性淋巴增生性疾病 (CLPD)(CD8+ 或 NK 衍生) | 上面未列出的其他 CD8+/NK 细胞驱动的淋巴瘤美国, 澳大利亚, 法国, 西班牙
-
Memorial Sloan Kettering Cancer Center招聘中蕈样肉芽肿 | 塞扎里综合症 | 血管免疫母细胞性T细胞淋巴瘤 | 肝脾T细胞淋巴瘤 | 间变性大细胞淋巴瘤,ALK 阳性 | 结外 NK/T 细胞淋巴瘤,鼻型 | T细胞淋巴瘤 | 未特指的外周 T 细胞淋巴瘤 | 原发性皮肤间变性大细胞淋巴瘤 | 皮下脂膜炎样 T 细胞淋巴瘤 | 肠病相关的T细胞淋巴瘤 | 间变性大细胞淋巴瘤,ALK 阴性 | 单形性趋上皮性肠 T 细胞淋巴瘤 | T 细胞幼淋巴细胞白血病 | T 细胞大颗粒淋巴细胞白血病 | 原发性皮肤 CD8 阳性侵袭性嗜表皮 T 细胞淋巴瘤 | Hydroa Vacciniforme-Like Lymphoproliferative Disorder | NK细胞淋巴瘤 | 侵袭性 NK 细胞白血病 | 成人 T 细胞白血病/淋巴瘤 及其他条件美国